Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Insulet Corp
(NQ:
PODD
)
268.00
+23.02 (+9.40%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Insulet Corp
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Gainers
Via
Benzinga
Why Insulet Stock Is Skyrocketing Today
November 04, 2022
Investors are cheering the company's strong Q3 results.
Via
The Motley Fool
Insulet Shares Jump After Q3 Earnings Surpass Expectations, Improved Annual Guidance
November 04, 2022
Via
Benzinga
FDA Approves Insulet's Omnipod Automated Insulin System For Patients Two Years & Above
August 22, 2022
Via
Benzinga
Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday
November 04, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
What 5 Analyst Ratings Have To Say About Insulet
November 04, 2022
Over the past 3 months, 5 analysts have published their opinion on Insulet (NASDAQ:PODD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 04, 2022
Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million.
Via
Benzinga
What 8 Analyst Ratings Have To Say About Insulet
August 05, 2022
Analysts have provided the following ratings for Insulet (NASDAQ:PODD) within the last quarter:
Via
Benzinga
Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance
August 05, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
Upgrades
Via
Benzinga
Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket
November 04, 2022
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday.
Via
Benzinga
Coinbase, DoorDash And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 04, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Insulet Reports Third Quarter 2022 Revenue Increase of 24% Year-Over-Year (29% Constant Currency1)
November 03, 2022
From
Insulet Corporation
Via
Business Wire
Insulet Recognizes World Diabetes Day and Diabetes Awareness Month Throughout November
November 01, 2022
From
Insulet Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
October 18, 2022
Upgrades
Via
Benzinga
Analyst Ratings for Insulet
October 12, 2022
Over the past 3 months, 6 analysts have published their opinion on Insulet (NASDAQ:PODD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
Upgrades
Via
Benzinga
Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022
September 22, 2022
From
Insulet Corporation
Via
Business Wire
Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System
September 20, 2022
From
Insulet Corporation
Via
Business Wire
Neurocrine Leads 5 Stocks To Watch In Sickly Market
September 03, 2022
Neurocrine Biosciences leads five medical stocks showing resilience.
Via
Investor's Business Daily
A Bullish Sign Appears On Insulet's Chart
September 01, 2022
If history is any guide, there may be good fortune ahead for shares of Insulet (NASDAQ:PODD). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the...
Via
Benzinga
$1000 Invested In Insulet 5 Years Ago Would Be Worth This Much Today
August 23, 2022
Insulet (NASDAQ:PODD) has outperformed the market over the past 5 years by 24.25% on an annualized basis producing an average annual return of 35.42%. Currently, Insulet has a market capitalization of...
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
Via
Benzinga
Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22
August 22, 2022
Reuters Vodafone To Sell Hungarian Business For $1.8B: Report
Via
Benzinga
FDA Clears Insulet's Omnipod 5 Automated Insulin Delivery System For Preschool Children
August 22, 2022
The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with...
Via
Benzinga
Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes
August 22, 2022
From
Insulet Corporation
Via
Business Wire
Insulet to Present at Upcoming Investor Conferences
August 05, 2022
From
Insulet Corporation
Via
Business Wire
Recap: Insulet Q2 Earnings
August 04, 2022
Insulet (NASDAQ:PODD) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Insulet missed estimated earnings by...
Via
Benzinga
Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency1)
August 04, 2022
From
Insulet Corporation
Via
Business Wire
Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System
August 01, 2022
From
Insulet Corporation
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.